Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Myelodysplastic Syndromes × pertuzumab × Clear all

Sponsor

Conditions

Breast Neoplasms 41 Ovarian Neoplasms 4 Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Solid Tumor 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Inflammatory Breast Neoplasms 2 HER2-positive Breast Cancer 2 Colonic Neoplasms 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Patient Preference 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Neoplasms, Unknown Primary 1 Multiple Endocrine Neoplasia 1 Malignant Solid Neoplasm 1 Lung Neoplasms 1 Locally Advanced Breast Cancer 1 Her2-Positive Breast Cancer 1 HER2-positive Metastatic Breast Cancer 1 HER2-positive Early Breast Cancer 1 Fallopian Tube Neoplasms 1 Carcinoma, Neuroendocrine 1 Carcinoid Tumor 1 Breast Neoplasms, Male 1 Biliary Tract Neoplasms 1

Interventions

fludarabine phosphate 76 Cyclophosphamide 70 Azacitidine 53 Whole-Body Irradiation 51 fludarabine 49 Mycophenolic Acid 46 Busulfan 46 Tacrolimus 42 Melphalan 36 Antilymphocyte Serum 34 Peripheral Blood Stem Cell Transplantation 33 Filgrastim 31 Cytarabine 31 Decitabine 30 Cyclosporine 27 Granulocyte Colony-Stimulating Factor 26 Methotrexate 25 thymoglobulin 21 Thiotepa 20 Cord Blood Stem Cell Transplantation 18 Clofarabine 18 Rituximab 15 Stem Cell Transplantation 14 Sirolimus 13 Lenalidomide 11 Etoposide 11 Alemtuzumab 11 venetoclax 9 Radiotherapy 9 sargramostim 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡